News About OTraces

May 8, 2018,
OTraces Presents at the New York Oncology Investors Conference

Click here to view the Slide Show Presented at the New York Oncology Conference Sponsored by the National Foundation for Cancer Research

Apr. 9, 2018,
OTraces TME Cancer Blood Test Video Presentation

Jan. 11, 2018,
OTraces’ TME Cancer Blood Test Presentation at Innovation Challenge Spurs Investor Interest from JP Morgan Healthcare Conference Participants.
Click here for JP Morgan Press Release.

Jan. 7, 2018,
OTraces Named as Finalist in RESI Investor Conference Technical Inovation Contest.
Click here for RESI Conference Press Release.

July 31, 2017,
GenomeWeb Publishes Article On OTraces Cancer Detection Technology
Click here for GenomeWeb Article.

Sept. 19, 2017,
Blood Test that Tracks Tumor Status and Progression — An Advance in Prostate Cancer Active Surveillance
Click here for Prostate Cancer Active Surveillance Test.

June 12, 2017,
OTraces Annouces Release of Technology White Paper on new Technology for High Disease Detection Predictive Power with Proteomic Noise Suppression
Click here for Proteomic Noise Suppression New Release.